HPHA.DE
Price:
$3.02
Market Cap:
$141.29M
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It is developing HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for tumors; and HDP-XX for the treatment of solid/hematological tumors. The company is also developing MGTA-ATACs for HSCs, conditioning programs to treat blood cancers/genetic diseases; TAK-ATACs for oncology...[Read more]
Industry
Biotechnology
IPO Date
2006-11-13
Stock Exchange
XETRA
Ticker
HPHA.DE
According to Heidelberg Pharma AG’s latest financial reports and current stock price. The company's current Current Ratio is 7.74. This represents a change of 15.33% compared to the average of 6.71 of the last 4 quarters.
The mean historical Current Ratio of Heidelberg Pharma AG over the last ten years is 2.80. The current 7.74 Current Ratio has changed 27.52% with respect to the historical average. Over the past ten years (40 quarters), HPHA.DE's Current Ratio was at its highest in in the February 2018 quarter at 8.12. The Current Ratio was at its lowest in in the May 2021 quarter at 0.20.
Average
2.80
Median
2.33
Minimum
0.60
Maximum
7.00
Discovering the peaks and valleys of Heidelberg Pharma AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 668.70%
Maximum Annual Current Ratio = 7.00
Minimum Annual Increase = -53.08%
Minimum Annual Current Ratio = 0.60
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 5.95 | 107.68% |
| 2023 | 2.86 | -8.97% |
| 2022 | 3.15 | 421.28% |
| 2021 | 0.60 | -46.82% |
| 2020 | 1.13 | -36.76% |
| 2019 | 1.79 | -53.08% |
| 2018 | 3.82 | -45.38% |
| 2017 | 7.00 | 668.70% |
| 2016 | 0.91 | 15.15% |
| 2015 | 0.79 | -14.34% |
The current Current Ratio of Heidelberg Pharma AG (HPHA.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.99
5-year avg
2.74
10-year avg
2.80
Heidelberg Pharma AG’s Current Ratio is less than 4basebio PLC (11.36), greater than Zura Bio Limited (5.58), greater than BRAIN Biotech AG (2.39), greater than Healwell AI Inc (0.69), greater than Mediclin AG (1.82), greater than FamiCord AG (0.65), greater than LIMES Schlosskliniken AG (3.25), greater than MPH Health Care AG (0.40), greater than Apontis Pharma AG (6.82), greater than H100 Group AB N (2.47),
| Company | Current Ratio | Market cap |
|---|---|---|
| 11.36 | $124.65M | |
| 5.58 | $230.16M | |
| 2.39 | $53.74M | |
| 0.69 | $123.51M | |
| 1.82 | $166.25M | |
| 0.65 | $92.39M | |
| 3.25 | $102.03M | |
| 0.40 | $82.42M | |
| 6.82 | $91.63M | |
| 2.47 | $76.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heidelberg Pharma AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Heidelberg Pharma AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Heidelberg Pharma AG's Current Ratio?
How is the Current Ratio calculated for Heidelberg Pharma AG (HPHA.DE)?
What is the highest Current Ratio for Heidelberg Pharma AG (HPHA.DE)?
What is the 3-year average Current Ratio for Heidelberg Pharma AG (HPHA.DE)?
What is the 5-year average Current Ratio for Heidelberg Pharma AG (HPHA.DE)?
How does the current Current Ratio for Heidelberg Pharma AG (HPHA.DE) compare to its historical average?